ZA911950B - Plasmodium sporozoite antigen - Google Patents

Plasmodium sporozoite antigen

Info

Publication number
ZA911950B
ZA911950B ZA911950A ZA911950A ZA911950B ZA 911950 B ZA911950 B ZA 911950B ZA 911950 A ZA911950 A ZA 911950A ZA 911950 A ZA911950 A ZA 911950A ZA 911950 B ZA911950 B ZA 911950B
Authority
ZA
South Africa
Prior art keywords
sporozoite antigen
plasmodium sporozoite
plasmodium
antigen
sporozoite
Prior art date
Application number
ZA911950A
Inventor
Ulrich Certa
Certa Ulrich
Maria Cuttinger
Cuttinger Maria
Hugues Matile
Matile Hugues
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA911950B publication Critical patent/ZA911950B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/35Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA911950A 1990-03-23 1991-03-15 Plasmodium sporozoite antigen ZA911950B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH97090 1990-03-23

Publications (1)

Publication Number Publication Date
ZA911950B true ZA911950B (en) 1991-11-27

Family

ID=4199439

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA911950A ZA911950B (en) 1990-03-23 1991-03-15 Plasmodium sporozoite antigen

Country Status (9)

Country Link
EP (1) EP0447956A1 (en)
JP (1) JPH0686679A (en)
AU (1) AU637468B2 (en)
CA (1) CA2037151A1 (en)
IE (1) IE910966A1 (en)
IL (1) IL97578A0 (en)
NZ (1) NZ237447A (en)
PT (1) PT97117A (en)
ZA (1) ZA911950B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996007910A1 (en) * 1994-09-02 1996-03-14 Meiji Milk Products Company Limited Diagnostic drug for chlamydia infection
DE60043708D1 (en) * 1999-10-13 2010-03-04 Novartis Vaccines & Diagnostic METHOD FOR MAINTAINING CELL IMMUNE RESPONSES AGAINST PROTEINS
RU2540871C2 (en) * 2008-02-01 2015-02-10 Альфа-О Пептидес Аг Self-assembling peptide nanoparticles effective as vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE78869T1 (en) * 1985-02-07 1992-08-15 Smithkline Beecham Corp MALARIA VACCINE.
GB8615068D0 (en) * 1986-06-20 1986-07-23 Wellcome Found Vaccines
EP0278941A1 (en) * 1987-01-30 1988-08-17 Smithkline Biologicals S.A. Expression of the P. falciparum circumsporozoite protein by yeast
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
FR2645877B1 (en) * 1989-04-12 1991-07-05 Pasteur Institut MOLECULES COMPRISING AT LEAST ONE PEPTIDE SEQUENCE CARRYING ONE, OR SEVERAL, CHARACTERISTIC EPITOPE OF A PROTEIN PRODUCED BY P. FALCIPARUM AT THE SPOROZOITE STAGE AND IN THE HEPATOCYTES
WO1991008756A1 (en) * 1989-12-12 1991-06-27 Biomedical Research Institute Novel malarial sporozoite peptide antigens

Also Published As

Publication number Publication date
PT97117A (en) 1991-11-29
CA2037151A1 (en) 1991-09-24
IL97578A0 (en) 1992-06-21
JPH0686679A (en) 1994-03-29
EP0447956A1 (en) 1991-09-25
AU637468B2 (en) 1993-05-27
AU7358991A (en) 1991-10-03
NZ237447A (en) 1993-05-26
IE910966A1 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
SG48314A1 (en) Improved antibodies to plasmodium falciparum
GB9001766D0 (en) Vaccines
IL96579A0 (en) Malaria vaccine
ZA911950B (en) Plasmodium sporozoite antigen
GB8905857D0 (en) Plasmodium merozoite rhoptries antigen
GB2251735B (en) Rectifier
GB9020438D0 (en) Plasmodium liver stage antigens
GB9014652D0 (en) Antigen
EP0550595A4 (en) Methods
GB9003678D0 (en) Badges
IL94257A0 (en) Malaria vaccine
GB9102294D0 (en) Antigen of plasmodium falciparum
GB2248024B (en) Base structure
EP0439678A3 (en) Inductor
GB9027381D0 (en) Decorative members
EP0516721A4 (en) Antigenic proteins of plasmodium
GB9020437D0 (en) Plasmodium liver stage antigens
GB9020464D0 (en) Plasmodium liver stage antigens
IE901300L (en) Plasmodium circumsporozoite protein analogues
RU1806857C (en) Cyclone
GB9017991D0 (en) Stairs
AU110705S (en) Brooch
AU110706S (en) Brooch
GB9202491D0 (en) Parasite antigens
GB9117602D0 (en) Novel antigens